YONGTAI TECH.(SZ:002326) Shang Hai Zheng Quan Bao·2025-08-25 20:04Summary of Key Points Core Viewpoint - Zhejiang Yongtai Technology Co., Ltd. has announced a guarantee for its subsidiary, Foshan Handxin Pharmaceutical Co., Ltd., with a principal amount of RMB 10 million, as part of a broader approval to provide guarantees totaling up to RMB 4.3 billion for certain subsidiaries [2][3]. Group 1: Guarantee Overview - The company has received approval from its shareholders to provide guarantees totaling no more than RMB 430 million for its subsidiaries, which can be used for various financing needs [2]. - The guarantee amount is divided based on the subsidiaries' debt-to-asset ratios: up to RMB 200 million for those with a ratio not exceeding 70%, and up to RMB 230 million for those exceeding 70% [2]. - The guarantee can be adjusted among subsidiaries, with specific conditions for those exceeding the 70% debt-to-asset ratio [2]. Group 2: Details of the Guarantee - The specific guarantee for Foshan Handxin includes a principal amount of RMB 10 million, with a guarantee method of joint liability [3][6]. - The guarantee period is set for three years from the maturity of the main contract, covering various financial obligations including principal, interest, penalties, and costs related to debt recovery [6][8]. Group 3: Financial Indicators and Risks - As of the announcement date, the company has a total guarantee balance of RMB 300.7 million for its subsidiaries, which represents 112.57% of the company's latest audited net assets [9]. - The company has no overdue guarantees or guarantees related to litigation, indicating a stable financial position regarding its guarantee obligations [9]. Group 4: Board's Opinion - The board believes that the financial risks associated with the guarantees are manageable and will not affect the company's normal operations, aligning with the overall development strategy [8]. - The board emphasizes that the subsidiary is under the company's absolute control, mitigating potential risks to the company and its minority shareholders [8].